Abstract
The rapidly activating and inactivating voltage-dependent outward K+ (Kv) current, IA, is widely expressed in central and peripheral neurons. IA has long been recognized to play important roles in determining neuronal firing properties and regulating neuronal excitability. Previous work demonstrated that Kv4.2 and Kv4.3 α-subunits are the primary determinants of IA in mouse cortical pyramidal neurons. Accumulating evidence indicates that native neuronal Kv4 channels function in macromolecular protein complexes that contain accessory subunits and other regulatory molecules. The K+ channel interacting proteins (KChIPs) are among the identified Kv4 channel accessory subunits and are thought to be important for the formation and functioning of neuronal Kv4 channel complexes. Molecular genetic, biochemical, and electrophysiological approaches were exploited in the experiments described here to examine directly the roles of KChIPs in the generation of functional Kv4-encoded IA channels. These combined experiments revealed that KChIP2, KChIP3, and KChIP4 are robustly expressed in adult mouse posterior (visual) cortex and that all three proteins coimmunoprecipitate with Kv4.2. In addition, in cortical pyramidal neurons from mice lacking KChIP3 (KChIP3−/−), mean IA densities were reduced modestly, whereas in mean IA densities in KChIP2−/− and WT neurons were not significantly different. Interestingly, in both KChIP3−/− and KChIP2−/− cortices, the expression levels of the other KChIPs (KChIP2 and 4 or KChIP3 and 4, respectively) were increased. In neurons expressing constructs to mediate simultaneous RNA interference-induced reductions in the expression of KChIP2, 3, and 4, IA densities were markedly reduced and Kv current remodeling was evident.
Introduction
The rapidly activating and inactivating voltage-dependent outward K+ (Kv) current, IA, is widely expressed in central and peripheral neurons (Rogawski, 1985). IA has long been recognized to play important roles in determining neuronal firing properties (Connor and Stevens, 1971a,b) and regulating neuronal excitability under normal (Aghajanian, 1985) and pathologic conditions, such as epilepsy (Bernard et al., 2004). Recent studies have also demonstrated that alterations in the functional expression of IA in dendritic compartments is important for regulating the backpropagation (into dendrites) of action potentials, synaptic potentiation, and dendritic integration (Cai et al., 2004; Makara et al., 2009). Recognition of the many important roles that IA plays in neuronal processing has focused considerable effort on understanding the mechanisms that determine the functional expression of IA channels.
Substantial progress has been made in understanding the roles of Kv pore-forming (α) subunits in the generation of IA. In hippocampal pyramidal and dorsal horn neurons, Kv4.2 α-subunits encode IA (Chen et al., 2006; Hu et al., 2006), whereas in dorsal root ganglion neurons and hippocampal interneurons, Kv4.3 has been suggested to generate IA (Bourdeau et al., 2007; Phuket and Covarrubias, 2009). In mouse cortical pyramidal neurons, however, IA is encoded by Kv4.2, Kv4.3, and Kv1.4 α-subunits (Norris and Nerbonne, 2010). Considerable evidence indicates that neuronal Kv4 channels function in macromolecular complexes that contain accessory subunits and other regulatory molecules (Schulte et al., 2006; Covarrubias et al., 2008; Marionneau et al., 2009). Multiple putative Kv4 accessory subunits have been identified including the following: Kvβ subunits (Aimond et al., 2005), dipeptidyl peptidase (DPP) family members (DPP6 and DPP10) (Nadal et al., 2003; Jerng et al., 2005), MinK/MiRP family members (Roepke et al., 2008), as well as K+ channel interacting proteins (KChIP1, KChIP2, KChIP3, and KChIP4) (An et al., 2000; Morohashi et al., 2002).
Several previous studies in heterologous expression systems have demonstrated that coexpression of one or more of these Kv channel accessory subunits dramatically alters the properties and functional expression of Kv4-encoded currents (Martens et al., 1999; Radicke et al., 2006; Maffie and Rudy, 2008). Coexpression with one of the KChIPs, for example, results in Kv4 currents that inactivate more slowly and recover from inactivation more quickly than the currents generated by Kv4 α-subunits expressed alone (An et al., 2000). Also, the coexpression of KChIPs markedly increases Kv4-encoded current densities (Shibata et al., 2003). Interestingly, heterologous coexpression of other accessory subunits, such as the DPPs and Kvβs, with Kv4 α-subunits also alters densities and properties of Kv4-encoded currents (Yang et al., 2001; Jerng et al., 2005). Although the many studies conducted in heterologous cells have informed our understanding of the interactions of accessory subunits with Kv4 α-subunits, little is presently known about the functional roles played by accessory subunits in the generation of native neuronal Kv4 channel complexes. A combination of biochemical and molecular genetic tools was exploited in the studies described here to examine directly the functional roles of the KChIPs in regulating/modulating Kv4-encoded currents in (mouse visual) cortical pyramidal neurons.
Materials and Methods
DNA constructs.
Plasmids containing the coding sequences for mouse Kv4.2, KChIP2, KChIP3, and KChIP4 were obtained from Open Biosystems. The KChIP4 clone used here encodes the same amino acid sequence as the variant termed KChIP4b (Holmqvist et al., 2002).
Plasmids encoding human microRNA30 (miR30) with substitutions made in the targeting sequence region (miRNA) and a fluorescent protein (see below) were constructed following a previously described approach (Du et al., 2006). Briefly, the miR30 sequence was placed between splice donor and acceptor sequences in an artificial intron. This arrangement allows the miRNA sequence to be spliced away from the transcript, so that a single transcript can be processed to mediate RNA interference (RNAi) and be used for translation to generate the encoded fluorescent protein. The miRNA intron plasmid was assembled by combining the human miR30 sequence from the pPrime system described by Stegmeier et al. (2005) with the chimeric intronic sequence taken from the Promega PCI-Neo vector. The miR30 sequence was placed in the branch region between the 5′ donor site and the 3′ acceptor site of the first intron of the human β-globin gene (Bothwell et al., 1981; Brondyk, 1995). The sequence containing miR30, as well as the exon and intron components, was synthesized to order by CelTek and subsequently cloned into the multicloning site of Clontech N-1 vectors, encoding either the enhanced yellow florescent protein (YFP) or the enhanced cyan florescent protein (CFP) at the Nhe1 and HindIII sites. To generate a red fluorescent version of the vector, the coding sequence was replaced with the sequence coding for the red fluorescent protein tdTomato (Shaner et al., 2004). Individual targeting sequences specific for KChIP2, 3, or 4 were obtained from Open Biosystems in pSM2C vectors or were designed using the RNAI Codex algorithm and shRNA designer tool (Olson et al., 2006) and synthesized (Sigma-Aldrich). Specific targeting hairpins were subsequently cloned into the XhoI and EcoRI sites in the miR30. Multiple targeting sequences for KChIP2, KChIP3, and KChIP4 were screened for effectiveness in reducing the expression of cotransfected target (mouse KChIP2, 3, or 4) when transfected at ratios of 1:1 in HEK-293 cells.
The targeting sequences that proved effective in reducing the expression of the targets were then used in subsequent experiments in neurons. The targeting 22-mer sequences used were as follows: for KChIP2, ATCCATGCAACTCTTTGATAAT, for KChIP3, TCCATGCAGCTGTTTGAGAAC, and for KChIP4, CCCAGAGCAAATTCACCAAGAA. BLAST searches confirmed that none of the targeting sequences for individual KChIPs had sequence homology to the other KChIPs or other known genes. The targeting sequence used for KChIP4 is complementary to both the KChIP4a and 4b splice variants. For control experiments, nontargeting (not complementary to any cDNA sequences in the mouse genome) hairpin sequences were used in the intron miRNA vector in place of the specific targeting hairpins. One control sequence targeted luciferase (Stegmeier et al., 2005) and the other was a scrambled sequence. For experiments, equal amounts of DNA for nontargeting and targeting vectors were transfected into neurons.
Isolation, maintenance, and transfection of cortical pyramidal neurons.
Neurons were isolated from the primary visual cortices of postnatal day 6–8 mice using previously described methods (Huettner and Baughman, 1986; Nerbonne et al., 2008). Briefly, each animal was anesthetized with isoflurane and rapidly decapitated. The brain was then removed and the posterior cortex dissected. The tissue containing the full thickness of the visual cortex was then dissected, chopped into small pieces, and incubated at 37°C in Neurobasal medium (Invitrogen) containing papain (66 U/ml) (Worthington Biochemicals) under 95% O2/5% CO2 for 30 min. Subsequent to the enzyme treatment, tissues pieces were triturated using fire-polished Pasteur pipettes. Isolated neurons were recovered by centrifugation for 15 min through a bovine serum albumin gradient. Cells were resuspended in Neurobasal medium and plated on previously prepared monolayers of rat cortical astrocytes (Huettner and Baughman, 1986). One hour after plating, Neurobasal medium was replaced with Minimum Essential Medium (Invitrogen) supplemented with 10% fetal bovine serum, 0.3% glucose, and 0.14 mm l-glutamine. Cell cultures were maintained in an incubator with 5% CO2 at 37°C.
Neurons were transfected using the Amaxa Nucleofector II and the Amaxa mouse hippocampal kit (Lonza) according to the directions from the manufacturer. For transfections, isolated neurons obtained by centrifugation through a bovine serum albumin gradient were resuspended in the solution included in the nucleofection kit plus the miRNA plasmids, subjected to electroporation, and resuspended in medium immediately before plating. Based on fluorescent protein expression, 48 h after transfections ∼10–30% of cells were transfected (data not shown).
Human embryonic kidney-293 cell culture and transfection.
Human embryonic kidney-293 (HEK-293) cells were maintained in DMEM supplemented with 5% fetal bovine serum, 5% horse serum, and penicillin/streptomycin (Invitrogen) in a 5% CO2 37°C incubator. HEK-293 cells were transfected using Lipofectamine 2000 (Invitrogen) and were maintained in Opti-MEM (Invitrogen) during the 8 h transfection period.
Electrophysiological recordings.
Recordings of whole-cell Kv currents were obtained from pyramidal shaped neurons on the second and third day in culture (∼48–72 h after plating) at room temperature (22–23°C). Process growth was limited during the first 3 d in culture, thereby allowing for adequate voltage clamp. Pyramidal shaped neurons expressing the microRNA constructs, as determined by fluorescent protein expression, were selected for recordings. Data were collected using an Axon 1D amplifier (Molecular Devices) interfaced to a personal computer (Dell), using a Digidata 1322 (Molecular Devices) analog-to-digital converter. Pipettes were fabricated from borosilicate glass (WPI) with a Sutter model P-87 horizontal puller (Sutter Instrument). For recordings, the bath solution routinely contained the following (in mm): 140 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 5 glucose, 0.001 TTX, and 0.1 CdCl2, pH 7.4 and 300 mOsM. The recording pipette solution contained the following (in mm): 135 KCl, 10 HEPES, 5 glucose, 1.1 CaCl2, 2.5 BAPTA, 3 MgATP, and 0.5 NaGTP, pH 7.4 and 300 mOsM. The calculated free Ca2+ in this BAPTA-buffered pipette solution was 100 nm (MaxChelator) (Patton et al., 2004). Using this pipette solution, pipette resistances were between 2 and 4 MΩ. All reagents were from Sigma-Aldrich unless otherwise noted.
For all experiments, junction potentials were zeroed before forming pipette–membrane seals. Signals sampled at 100 kHz and low-pass filtered at 10 kHz. Whole-cell Kv currents were evoked in response to 4 s depolarizing voltage steps to potentials between −40 and +40 mV (in 10 mV increments) from a holding potential of −70 mV. Also, a prepulse paradigm, which included a 60 ms step to −10 mV before steps to test potentials from −40 to +40 mV (in 10 mV increments), was used to facilitate the isolation of the rapidly inactivating currents in each cell. Subsequent off-line subtraction of the current records obtained with the prepulse from the current records obtained without the prepulse (in the same cell) allowed the isolation of the rapidly inactivating outward K+ currents (see Fig. 1).
Data analysis.
Data were compiled and analyzed using ClampFit (Molecular Devices), Microsoft Excel, and Prism (GraphPad). Only data from cells with input resistances >300 MΩ and access resistances <15 MΩ were included in the analyses. Membrane capacitances were determined by analyzing the decay phases of capacitive currents elicited by short (25 ms) voltage steps (±10 mV) from the holding potential (−70 mV). Consistent with the limited outgrowth of processes during the first 3 d in culture, a single exponential was sufficient to describe the decay phases of the capacitive transients. Whole-cell membrane capacitances (Cm) were calculated for each cell by dividing the integrated capacitive transients by the voltage. Input resistances were calculated from the steady-state currents elicited by the same ±10 mV steps (from the holding potential of −70 mV). For each cell, the series resistance was calculated by dividing the time constant of the decay of the capacitive transient by the Cm; the mean (±SEM) series resistance was 5.8 ± 0.1 MΩ (n = 155). Series resistances were compensated electronically by >80% in all cells. Voltage errors resulting from uncompensated series resistances, therefore, were small (<2 mV) and were not corrected. The inactivation phases of the Kv currents were analyzed using the following equation: y = A1e-t/τ1 + A2e-t/τ2 + A3e-t/τ3 + C, where A1, A2, and A3 are the amplitudes of individual current components (see text), each with a characteristic time constant of decay (τ1, τ2, and τ3), and C is the non-inactivating component (ISS) of the total Kv current (Locke and Nerbonne, 1997a). Statistical analyses were conducted using Prism. The statistical significance of observed differences in current–voltage plots (IV plots) was calculated using repeated-measurement ANOVA. The Mann–Whitney test was used to examine the statistical significance of the differences of the mean ± SEM of results from Western blot and quantitative real-time PCR (QRT-PCR) data. The column t test was used for statistical analyses of results obtained in the experiments that examined the expression levels of heterologously expressed Kv4.2 and KChIPs.
Immunoprecipitation and Western blots.
For the isolation of tissue for biochemical analyses, mice were anesthetized with isoflurane and rapidly decapitated, and the brains were removed. The posterior (∼1 mm) cortex, which contains visual areas, was dissected and flash frozen in liquid nitrogen. Tissue samples were collected from wild-type (WT) C57BL/6 mice and mice (Kv4.2−/−, Kv4.3−/−, KChIP2−/−, and KChIP3−/−) harboring targeted disruptions of the genes encoding Kv4.2 (Kcnd2) (Guo et al., 2005; Nerbonne et al., 2008), Kv4.3 (Kcnd3) (Niwa et al., 2008), KChIP2 (Kcnip2) (Kuo et al., 2001), and KChIP3 (Kcnip3) (Alexander et al., 2009). Also, samples from mice (Kv4.2−/−/Kv4.3−/−) generated by breeding Kv4.2−/− and Kv4.3−/− animals were used (Norris and Nerbonne, 2010).
For experiments focused on examining the expression of the KChIP and Kv4 proteins, total protein samples from posterior cortices collected from adult (WT, Kv4.2−/−, Kv4.2−/−, Kv4.3−/−/Kv4.3−/−, KChIP2−/−, and KChIP3−/−) mice were prepared using previously described methods (Brunet et al., 2004). Protein concentrations were determined for each sample using a Bio-Rad protein assay kit (Bio-Rad) following the directions from the manufacturer. Equal amounts of proteins were then fractionated by SDS-PAGE and transferred to polyvinylidene fluoride (PVDF) membranes. For immunoblotting, PVDF membranes with bound proteins were incubated in blocking buffer (PBS, 1% Tween, and 5% dry milk) for 1 h at room temperature. Membranes were then incubated overnight at 4°C with primary antibodies against Kv4.2, Kv4.3, or the individual KChIPs (KChIP2, KChIP3, and KChIP4). All primary antibodies were from the University of California, Davis/National Institutes of Health NeuroMab Facility with the exception of the goat anti-KChIP4 antibody from Santa Cruz Biotechnology. Bound primary antibodies were detected using horseradish peroxidase-conjugated rabbit anti-mouse IgG (GE Healthcare) or rabbit anti-goat IgG (Bethyl Labs) and the Durawest chemiluminescence reagent (Pierce). Signals were detected and quantified using the Bio-Rad Chemidoc system and the Quantity One software (Bio-Rad). Blots were then reprobed with primary antibodies against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Abcam), transferrin receptor (Invitrogen), or β-tubulin (Sigma-Aldrich) to verify equal protein loading in each lane. For quantification, the signals from the anti-GAPDH, the anti-transferrin receptor, or the anti-β-tubulin antibodies were used to normalize the anti-Kv4 or anti-KChIP signals for each lane on the same blot, as described in the text.
For immunoprecipitations, posterior cortical tissue samples from adult WT and Kv4.2−/− mice were processed, and immunoprecipitations were conducted using previously described methods (Marionneau et al., 2009). Briefly, the tissues pieces were homogenized in ice-cold lysis buffer: PBS [containing the following (in mm): 136 NaCl, 2.6 KCl, 10 NaH2PO4, 1.7 KH2PO4, pH 7.4] plus one protease inhibitor mixture tablet (Roche) and Triton X-100 (1%). After 15 min rotation at 4°C, 4 mg of the soluble protein fractions from the WT and Kv4.2−/− brains were used for immunoprecipitations with 5 μg of an anti-Kv4.2 rabbit polyclonal antibody (Millipore). Protein A-magnetic beads (Invitrogen) were incubated with the protein samples and antibodies for 2 h at 4°C. Magnetic beads and bound antibodies were then collected and washed four times with ice-cold lysis buffer, and isolated protein complexes were eluted from the beads in 1× NuPAGE LDS sample buffer (Invitrogen). Samples were then fractionated by SDS-PAGE gels and transferred to PVDF membranes for immunoblotting as described above.
Protein lysates were prepared from HEK-293 cells harvested 24 h after transfections using ice-cold PBS containing 1% Triton and protease inhibitor (Complete mini EDTA ad libitum protease inhibitor mixture tablet from Roche) and processed for Western blot analysis described above for cortical samples.
Quantitative real-time PCR.
For QRT-PCR experiments, posterior cortical samples were collected from WT, Kv4.2−/−, Kv4.3−/−, Kv4.2−/−/Kv4.3−/−, and KChIP3−/− mice as described above. RNA was isolated from cortical samples and cDNA was produced using standard methods (Mullis and Faloona, 1987). Briefly, RNA was isolated by using the RNeasy mini kit from QIAGEN according the directions from the manufacturer, and RNA concentrations were determined by optical density measurements. Single-stranded cDNA was produced from 2 μg of total isolated RNA using the High Capacity cDNA Archive kit from Applied Biosystems. The expression levels of KChIP2, 3, and 4 were determined using sequence specific primers (see below) and SYBR Green (Applied Biosystems) for QRT-PCR; experiments were conducted on a 7900HT Fast Real-Time PCR System (Applied Biosystems). Data were analyzed using the threshold cycle relative quantification method, with GAPDH as the endogenous control. Primer sequences used to detect KChIP expression were as follows: KChIP2, forward, GGCTGTATCACGAAGGAGGAA; reverse, CCGTCCTTGTTTCTGTCCATC; KChIP3, forward, GGAGATCCTGGGCGCATAC; reverse, GTGAACCGTGGCCTTTGC; and KChIP4, forward, TGATCGTCATTGTGCTTTTTGTT; reverse, GCTGTCTTCTAAACCTGCTTCAATC.
Results
Disruption of KChIP3 expression decreases IA density in cortical pyramidal neurons
The finding that expression of KChIP3 protein was markedly decreased in the cortices of mice harboring a targeted disruption of the Kcnd2 (Kv4.2) locus (Nerbonne et al., 2008) suggested that KChIP3 may play an important role in the generation of functional Kv4-encoded IA channels in cortical neurons. To explore this hypothesis, whole-cell Kv currents, evoked in response to steps to depolarized potentials (−40 through +40 mV in 10 mV increments) from a holding potential of −70 mV, were examined in cortical pyramidal neurons isolated from WT and KChIP3−/− mice. The waveforms of the Kv currents recorded from WT (Fig. 1A) and KChIP3−/− (Fig. 1B) neurons were similar, with prominent rapidly inactivating current components (IA). To facilitate the quantification of IA, Kv currents were also recorded from each cell using a prepulse paradigm (Fig. 1A, b; B, b) to inactivate IA selectively (Norris and Nerbonne, 2010); an additional 60 ms step to −10 mV was included before the depolarizing voltage steps (see paradigm illustrated in Fig. 1). Off-line subtraction of the records obtained using the prepulse paradigm from the control records (obtained from the same cell) allowed the isolation of IA (Fig. 1A, a − b; B, a − b).
Analysis of IA amplitudes in these subtracted records revealed that the mean ± SEM IA density was modestly, but significantly (p < 0.05), lower in KChIP3−/− (n = 24), compared with WT (n = 22), cortical pyramidal neurons (Fig. 1C). The voltage dependence of activation and the mean ± SEM τ of inactivation of the residual IA in KChIP3−/− neurons were not significantly different from the values determined for IA in WT neurons (data not shown). Technically, changes in the voltage dependence of inactivation could also result in changes in IA density. As described previously (Andreasen and Hablitz, 1992; Song et al., 1998; Wickenden et al., 1999), however, the presences of Cd2+ in the bath solution (to block Ca2+ channels) shifts the voltage dependence of activation and of steady-state inactivation of native IA to more depolarized voltages. At −70 mV, the holding potential used in the experiments here, all of the IA channels are available to be activated. The reduced IA density in KChIP3−/− pyramidal neurons, therefore, likely does not reflect a shift in IA channel availability.
In addition to the rapidly inactivating IA, previous studies (Locke and Nerbonne, 1997a,b; Yuan et al., 2005; Nerbonne et al., 2008; Norris and Nerbonne, 2010) have identified the presence of additional Kv currents in cortical pyramidal neurons: ID, which inactivates more slowly than IA (τ inactivation, ∼250 ms); IK, which inactivates very slowly (τ inactivation, ∼2 s); and the non-inactivating current, ISS. Analysis of the decay phases of Kv currents in WT and KChIP3−/− neurons revealed that, unlike IA, the mean ± SEM amplitudes/densities of ID, IK, and ISS were not significantly affected by the loss of KChIP3 (data not shown). The selective reduction of IA in KChIP3−/− cortical pyramidal neurons suggests that KChIP3 plays an important role in the generation and/or functioning of Kv4 channel complexes. The magnitude of IA remaining in KChIP3−/− cortical pyramidal neurons (Fig. 1C) also suggests that other KChIPs likely contribute to the generation of functional Kv4 channels. To examine the possible role of KChIP2, Kv current recordings were obtained from neurons isolated from mice (KChIP2−/−) harboring a targeted disruption of the gene (Kcnip2) encoding KChIP2 (Kuo et al., 2001). Analysis of the Kv currents using the prepulse paradigm described above, however, revealed that the mean ± SEM IA density in KChIP2−/− neurons (n = 19) was not significantly different from WT cells (n = 22) (not illustrated).
Coregulated expression of KChIP2, 3, and 4 in visual cortex
Previous studies have suggested that expression of KChIP1 is restricted to nonpyramidal interneurons in the cortex (Rhodes et al., 2004; Lein et al., 2007). As a result, KChIP1 was not considered in the analysis here. As illustrated in Figure 2A, mRNA transcripts encoding KChIP2, KChIP3, and KChIP4 were readily detected in RNA samples collected from the posterior (∼1 mm) cortices of WT mice (see Material and Methods) consistent with previous reports examining KChIP expression in rodent brain (Rhodes et al., 2004; Xiong et al., 2004). Immunoprecipitation experiments using a rabbit anti-Kv4.2 antibody revealed that Kv4.2 was readily detected in fractionated protein samples from WT cortices, but not in samples from Kv4.2−/− cortices. Also consistent with previous reports (Guo et al., 2002; Rhodes et al., 2004; Marionneau et al., 2009), Kv4.3 coimmunoprecipitated with Kv4.2 from WT cortical samples (Fig. 2B). No Kv4.3, however, was detected (Fig. 2B) in the samples from Kv4.2−/− cortices, indicating that the anti-Kv4.2 antibody does not immunoprecipitate Kv4.3 in the absence of Kv4.2 and does not, therefore, cross-react with Kv4.3. KChIP2, KChIP3, and KChIP4 also coimmunoprecipitated with Kv4.2 from WT, but not Kv4.2−/−, cortical samples (Fig. 2C). The finding that KChIP2, KChIP3, and KChIP4 coimmunoprecipitate with Kv4.2 further suggests a role for each of these KChIPs in the generation of Kv4.2 channel complexes in cortical pyramidal neurons.
In parallel experiments, fractionated protein samples prepared from WT and KChIP3−/− cortices (n = 6 animals for each genotype) were probed with specific anti-KChIP2, anti-KChIP3, and anti-KChIP4 antibodies (Fig. 3A). The signals from each anti-KChIP antibody were measured and normalized to the signal from the anti-β-tubulin antibody in the same lane. Quantitative analysis of multiple blots revealed that the mean ± SEM expression levels of both KChIP2 and KChIP4 were significantly (p < 0.02) higher in the KChIP3−/−, relative to the WT, samples (Fig. 3B). Parallel experiments on KChIP2−/− cortical lysates revealed that the mean ± SEM protein levels of both KChIP3 and KChIP4 were significantly (p < 0.002) higher in KChIP2−/− compared with WT, samples (Fig. 3A,B). To explore the role of transcriptional remodeling, RNA was isolated from the (posterior) cortices of KChIP3−/− and WT mice (n = 6 for each genotype), and KChIP2 and KChIP4 transcript expression levels were examined. As illustrated in Figure 3C, the mean ± SEM expression level of the transcript encoding KChIP2 was similar in KChIP3−/− and WT samples. The mean ± SEM level of KChIP4 transcript expression was significantly (p < 0.05) higher in KChIP3−/−, relative to WT cortices, although the magnitude (∼30%) of the increase was much smaller than the twofold increase in KChIP4 protein expression.
Parallel experiments were completed to examine the expression levels of the Kv4.2 and Kv4.3 proteins in KChIP2−/− and KChIP3−/− cortices. In contrast to the marked changes in KChIP protein expression, analyses of Western blots on fractionated protein lysates prepared from the (posterior) cortices of KChIP2−/−, KChIP3−/−, and WT mice (n = 6 for each genotype) probed with specific antibodies against either Kv4.2 or Kv4.3 (Fig. 4A) revealed that the mean ± SEM expression levels of the Kv4.2 and Kv4.3 proteins were not significantly different in samples from KChIP2−/− or KChIP3−/−, relative to WT, cortices (Fig. 4B).
miRNA-mediated RNAi knockdown of KChIP2, 3, and 4 expression
The biochemical experiments presented above suggest that the KChIPs are able to compensate for one another. An RNAi-based strategy was developed, therefore, to allow for the simultaneous knockdown of KChIP2, 3, and 4 expression in cortical pyramidal neurons. Briefly, using a previously described approach (Du et al., 2006), plasmids encoding a targeting miRNA and a fluorescent protein (CFP, YFP, or tdtomato) were designed such that both components are present in a single transcript that is spliced apart and the components are processed separately (as illustrated in Fig. 5A). Separation of the miRNA and the fluorescent protein coding sequences by RNA splicing enhances the expression the fluorescent protein because the coding region is not degraded during the processing of the miRNA (Du et al., 2006), allowing for robust expression of the fluorophore as a faithful reporter of miRNA expression in transfected neurons. The miRNA plasmids described here allowed for the visual identification of transfected neurons expressing multiple miRNA constructs (as illustrated in Fig. 5B) for subsequent electrophysiological recordings.
Constructs containing individual sequences targeting KChIP2, KChIP3, or KChIP4 were cotransfected into HEK-293 cells with a plasmid encoding the targeted KChIP to identify sequences able to suppress the expression of each of the KChIPs. The effectiveness of each targeting sequence in reducing the expression of the targeted KChIP, compared with nontargeting control sequence, was assayed using Western blots performed on lysates prepared from transfected (HEK-293) cells. Of the individual sequences tested, those listed in Materials and Methods markedly suppressed the expression of KChIP2, KChIP3, or KChIP4 (Fig. 5C) and were used in subsequent experiments in neurons. Each of the miRNA sequences was specific to the targeted KChIP (i.e., none was complementary to mRNA sequences encoding KChIPs other than the targeted KChIP).
Knockdown of KChIP4 expression in KChIP3−/− neurons decreased IA density
The finding that the KChIP4 protein is upregulated in KChIP3−/− (and in KChIP2−/−) neurons (and may compensate for the loss of KChIP3 or KChIP2) was initially surprising because previous reports have suggested that KChIP4 acts to suppress, rather than promote, the surface expression of Kv4 channels (Shibata et al., 2003; Schwenk et al., 2008). To test directly the hypothesis that KChIP4 plays a role in the expression of functional Kv4-encoded IA channels, Kv current recordings were obtained from KChIP3−/− neurons transfected with a plasmid encoding either the control (nontargeting) miRNA (Fig. 6A) or the miRNA targeting KChIP4 (Fig. 6B). Parallel recordings were obtained from neurons expressing one (of the two) control nontargeting plasmids. One of these contained a scrambled targeting sequence (n = 17), and the other contained a control sequence targeting luciferase (n = 20). Analysis of the current records revealed no differences and the results were pooled.
Analysis of subtracted records (Fig. 6A,B, a − b) from KChIP3−/− neurons transfected with control (n = 37) or KChIP4 targeting (n = 16) plasmids revealed that mean ± SEM IA density was significantly (p < 0.05) lower in neurons expressing the KChIP4 targeting miRNA, compared with cells transfected with control miRNA (Fig. 6C). As illustrated in Figure 6B, the knockdown of KChIP4 in KChIP3−/− neurons resulted in marked changes in the Kv current waveforms, changes reminiscent of those previously described in Kv4.2−/− cortical pyramidal neurons (Nerbonne et al., 2008; Norris and Nerbonne, 2010). Analysis of the inactivation phases of the Kv currents revealed that the mean ± SEM amplitudes of the delayed rectifier currents, IK and ISS, were significantly (p < 0.01) larger in KChIP3−/− neurons expressing the KChIP4 targeting miRNA, compared with KChIP3−/− neurons transfected with control miRNA (Fig. 6D). In contrast, the mean ±SEM densities of ID were not significantly different in control and KChIP4 targeting miRNA-expressing cells (Fig. 6D).
Attenuation of Kv4-encoded currents and remodeling of Kv currents with simultaneous knockdown of KChIP2, 3, and 4 in Kv1.4−/− neurons
The results of the experiments described above suggest that KChIP2, KChIP3, and KChIP4 all contribute to the generation of functional of Kv4 channels and, in addition, that the KChIPs functionally compensate for one another. Experiments were undertaken, therefore, to examine the effects of concurrently knocking down the expression of KChIP2, 3, and 4 on Kv4-encoded IA. These experiments were performed in neurons isolated from mice (Kv1.4−/−) harboring a targeted disruption of the gene (Kcna4) encoding for Kv1.4 to allow for the analysis of effects on Kv4-encoded IA without contamination from the Kv1.4-encoded component of IA (Norris and Nerbonne, 2010). Whole-cell Kv current recordings were obtained from Kv1.4−/− neurons (n = 20) visually identified to be expressing the three miRNA constructs targeting KChIP2, 3, and 4 or neurons (n = 21) transfected with control plasmids (Fig. 7A,B). Analyses of the subtracted current records revealed residual Kv4-encoded IA in all Kv1.4−/− neurons expressing the three KChIP targeting miRNA constructs. In addition, the voltage dependence of activation and the mean ± SEM τ of inactivation of the residual IA (data not shown) were similar to values determined in WT neurons (see Discussion). The mean ± SEM IA density, however, was significantly (p < 0.001) lower in Kv1.4−/− neurons expressing all three of KChIP targeting miRNA compared with Kv1.4−/− neurons expressing control constructs (Fig. 7C).
In addition to the marked reductions in IA densities in the subtracted current records (a − b), the Kv current waveforms in Kv1.4−/− neurons expressing the KChIP targeting miRNAs were quite heterogeneous. In approximately one-half (11 of 20) of the Kv1.4−/− neurons expressing the KChIP targeting miRNAs, no prominent rapidly inactivating current component was evident and delayed rectifier Kv currents were increased (Fig. 7B) reminiscent of the Kv current waveforms in Kv4.2−/− neurons, in which upregulated IK and ISS mask the residual IA (Nerbonne et al., 2008; Norris and Nerbonne, 2010). In the remaining Kv1.4−/− neurons expressing the KChIP targeting miRNAs (9 of 20), a rapidly inactivating component was clearly evident in the macroscopic Kv current waveforms (not illustrated). The marked alteration in the Kv current waveforms and the masking of the residual IA component in many of the Kv1.4−/− neurons expressing the KChIP targeting miRNAs (Fig. 7B) suggests a greater upregulation in the amplitudes of IK and ISS than in KChIP3−/− neurons expressing the KChIP4 targeting miRNA (Fig. 6D). Consistent with remodeling of IK and ISS, mean ± SEM peak Kv current densities were not significantly different in neurons expressing the three KChIP targeting miRNA constructs, compared with those expressing control miRNA constructs (Fig. 7D), despite the marked decrease in mean IA densities (Fig. 7C).
Expression of KChIP2, 3, and 4 proteins depends on the expression of Kv4 α-subunit proteins
The observed decreases in KChIP protein expression in Kv4.2−/− cortices (and other brain regions) suggest that KChIP protein expression is directly linked to Kv4.2 expression (Menegola and Trimmer, 2006; Nerbonne et al., 2008). To test this hypothesis directly, HEK-293 cells were transfected with DNA constructs encoding Kv4.2 alone, one of the KChIPs alone, or Kv4.2 and one of the KChIPs. As illustrated in Figure 8A, coexpression of Kv4.2 with KChIP2 (n = 6), KChIP3 (n = 9), or KChIP4 (n = 6) resulted in significant (p < 0.05) increases in mean ± SEM Kv4.2 protein levels (Fig. 8B) compared with cells (n = 9) expressing Kv4.2 alone. In addition, expression of Kv4.2 increased KChIP protein expression (Fig. 8C), and mean ± SEM KChIP2, KChIP3, and KChIP4 protein levels were significantly (p < 0.05) higher with coexpression of Kv4.2 compared with cells expressing each of the KChIPs alone (Fig. 8D).
To explore the hypothesis that the expression of the KChIP2, KChIP3, and KChIP4 proteins is linked to expression of the Kv4 α-subunit proteins in cortical neurons, Western blots on fractionated proteins from the posterior cortices of adult WT (n = 6), Kv4.2−/− (n = 6), Kv4.3−/− (n = 6), and Kv4.2−/−/Kv4.3−/− (n = 3) mice were probed with antibodies specific for KChIP2, KChIP3, or KChIP4 (Fig. 9). Blots were subsequently probed with an anti-β-tubulin antibody to confirm equal loading of proteins in each lane. Quantitative analysis revealed that the mean ± SEM expression levels of the KChIP2, KChIP3, and KChIP4 proteins were significantly (p < 0.01) lower in Kv4.2−/− samples, compared with WT samples (Fig. 9B). Also, relative to WT samples, the mean ± SEM expression levels of the KChIP2, KChIP3, and KChIP4 proteins were significantly (p < 0.01) lower in Kv4.3−/− samples. In addition, when samples from Kv4.2−/−/Kv4.3−/− animals were examined, the KChIP2, KChIP3, and KChIP4 proteins were barely detectable (Fig. 9).
In contrast, QRT-PCR analysis of RNA samples from posterior cortices of Kv4.2−/− (n = 6), Kv4.3−/− (n = 6), and Kv4.2−/−/4.3−/− (n = 3) mice revealed that the mean expression levels of the KChIP2, KChIP3, or KChIP4 transcripts were not lower in any of the genotypes relative to WT cortices. In fact, the only significant (p < 0.05) changes observed were increased (mean ± SEM) KChIP4 transcript expression in both the Kv4.3−/− and Kv4.2−/−/Kv4.3−/− samples (Fig. 9C). In contrast to the near-complete loss of the KChIP2, KChIP3, and KChIP4 proteins in the Kv4.2−/−/Kv4.3−/− cortices, there were no significant changes in mean ± SEM KChIP2 or KChIP3 transcript expression levels. The dramatic decreases in the expression levels of the KChIP proteins resulting from the disruption of Kv4.2 and/or Kv4.3 without corresponding decreases in mRNA levels are consistent with an important role for posttranscriptional mechanisms in the coupling between the expression of the KChIPs and the expression of the Kv4.2 and Kv4.3 α-subunits.
Discussion
KChIP2, KChIP3, and KChIP4 are critical components of functional Kv4 channel complexes in cortical pyramidal neurons
The results of the biochemical, molecular genetic, and electrophysiological experiments described here suggest that KChIP2, KChIP3, and KChIP4 are critical for the formation of functional Kv4 channel complexes in (mouse visual) cortical pyramidal neurons. All three KChIPs are robustly expressed in posterior cortex and, in addition, coimmunoprecipitate with Kv4.2 (Fig. 2). The results of the experiments completed here further indicate that the KChIPs can functionally compensate for one another. Specifically, the protein expression levels of the unperturbed KChIPs were upregulated in the cortices of KChIP2−/− and KChIP3−/− mice (Fig. 3), and IA densities were either not (KChIP2−/−) or only modestly (KChIP3−/−) affected (Fig. 1). Additional experiments revealed, however, that the simultaneous RNAi-mediated reduction in the expression of KChIP2, KChIP3, and KChIP4 resulted in marked reductions in Kv4-encoded IA densities (Fig. 7). Perhaps not surprisingly, IA was not completely eliminated in the Kv1.4−/− neurons expressing the three KChIP targeting miRNA constructs, consistent with residual KChIP protein, likely reflecting incomplete knockdown of KChIP2, 3, and/or 4 expression.
Expression of KChIP proteins is dependent on the expression of Kv4 α-subunits
The results of the experiments detailed here also revealed that the expression of the KChIP2, KChIP3, and KChIP4 proteins is dependent on the expression of Kv4 α-subunits in cortical tissue. Consistent with previous reports that KChIP2 and KChIP3 expression is decreased in Kv4.2−/− hippocampal neurons (Menegola and Trimmer, 2006), the results here demonstrate that protein expression levels of KChIP2, KChIP3, and KChIP4 are decreased in the cortices of Kv4.2−/−mice. Reduced expression of the KChIP2, 3, and 4 proteins was also observed in cortical samples from Kv4.3−/− mice. Additionally, all three KChIP proteins were barely detectable in Kv4.2−/−/Kv4.3−/− cortices (Fig. 9). Importantly, the marked reductions in the expression levels of KChIP proteins do not reflect changes in transcript levels (Fig. 9C), suggesting that posttranslational mechanisms are responsible for the loss of KChIP proteins in Kv4.2−/−, Kv4.3−/−, and Kv4.2−/−/Kv4.3−/− neurons.
Previous reports indicate that the KChIPs interact with Kv4 α-subunits early during channel biogenesis (Hasdemir et al., 2005; Flowerdew and Burgoyne, 2009). The results of experiments presented here suggest that, when the KChIP and Kv4 α-subunits bind, the proteins are stabilized, leading to increased levels of both the Kv4 α-subunit and accessory KChIP proteins (Fig. 8). The observed increases in the protein expression levels of the remaining KChIP proteins in KChIP2−/− and KChIP3−/− cortices (Fig. 3) suggest that, when the expression of an individual KChIP is disrupted, the remaining KChIP proteins are stabilized by binding to available Kv4 α-subunits, resulting in net increases in the nondisrupted KChIP proteins. Interestingly, the codependence of the expression of Kv α- and accessory subunit proteins has been previously reported in studies using Caenorhabditis elegans (Bianchi et al., 2003) and Drosophila (Wu et al., 2010), suggesting that the mechanisms linking accessory and α-subunits expression are highly conserved.
Functions of KChIP2, 3, and 4
Interestingly, results from several recent studies suggest that individual KChIPs may interact with specific signaling molecules (e.g., PKA or PKC) to regulate the modulation of Kv4 channels by specific signaling pathways (Schrader et al., 2002; Lin et al., 2010). Additional diversity of KChIP function may originate from splice variants of the individual KChIP genes. Splice variants of KChIP2 and KChIP4, for example, have been described to promote surface expression of heterologously expressed Kv4 α-subunits, and other variants have been reported to have inhibitory effects on the surface expression of Kv4 α-subunits (Shibata et al., 2003; Decher et al., 2004). It was also recently reported that KChIP3 (but not other KChIPs) functions as a Ca2+ sensor to modulate the voltage dependence of inactivation of Kv4-encoded IA in response to the entry of Ca2+ through Cav3-encoded voltage-gated Ca2+ channels (Anderson et al., 2010a,b). The findings presented here raise the interesting possibility that KChIP2 and KChIP4, in addition to KChIP3, also participate in the generation and functioning of distinct Kv4 channel complexes in cortical pyramidal neurons. Future experiments designed to explore this hypothesis are necessary to determine the unique roles of each of the individual KChIPs.
The results presented here, which indicate that multiple KChIPs are concurrently involved in the generation and function of Kv4 channels, highlight the molecular diversity that likely exists in Kv4 channel complexes in neurons. One Kv4 channel complex could, for example, be formed by a heterometric complex of Kv4.2 and Kv4.3 α-subunits bound simultaneously to multiple different KChIPs. In the same cell, another Kv4 channel complex could be formed by a homomultimer of Kv4.2 α-subunits with a single type of KChIP. As suggested previously, considerable evidence supports the additional inclusion of DPP6 and/or DPP10 subunits, as well as Kvβ subunits in the generation and/or functioning of Kv4 channel complexes (Nadal et al., 2003; Aimond et al., 2005; Jerng et al., 2005; Marionneau et al., 2009), thus exponentially diversifying the possible protein combinations that may be present in native neuronal Kv4 channel complexes. This molecular diversity may provide for high-resolution regulatory mechanisms for fine-tuning neuronal excitability and neuronal computations.
In addition to playing crucial roles as Kv4 channel accessory subunits, KChIPs have been shown to play important roles in other cellular processes (Buxbaum, 2004; Sours-Brothers et al., 2009). Notably, KChIP3, also called calsenilin (Buxbaum et al., 1998) and downstream regulatory element antagonist modulator (DREAM) (Carrión et al., 1999), has also been shown to modulate γ-secretase activity (Lilliehook et al., 2003), to alter gene transcription, and to function in apoptosis (Jo et al., 2001). Recently, it was reported that KChIP3/DREAM also modulates the NMDA class glutamate receptors in hippocampal neurons (Zhang et al., 2010). It is not clear how these (or other possible) functions of the KChIPs can be reconciled with the results presented here or with previously published results (Menegola and Trimmer, 2006), which clearly suggest that the expression of the KChIP proteins depends directly on the expression of Kv4 channel α-subunits. The possibility the KChIPs, particularly KChIP3, may coordinate the regulation of channel function with other cellular processes is an intriguing possibility that merits additional consideration and direct evaluation.
Remodeling of Kv currents after the disruption of KChIP expression
Remodeling of Kv currents was evident in KChIP3−/− neurons expressing KChIP4 targeting miRNA (Fig. 6) and in Kv1.4−/− neurons expressing miRNAs targeting KChIP2, 3, and 4 (Fig. 7). The upregulation of the IK and ISS components observed when the expression of multiple KChIPs was simultaneously disrupted is similar to the remodeling evident in Kv4.2−/−, Kv4.3−/−, and Kv4.2−/−/Kv4.3−/− cortical pyramidal neurons previously reported (Nerbonne et al., 2008; Norris and Nerbonne, 2010). Interestingly, no remodeling of Kv currents was evident in response to the loss of Kv4-encoded IA by the expression of a dominant-negative Kv4 construct in (rat) cortical pyramidal neurons (Yuan et al., 2005), suggesting that the mechanisms mediating the remodeling of ionic currents are based on protein expression rather than changes in the electrical properties of the neurons. A similar conclusion was reached in previous studies on lobster pyloric neurons, in which it was demonstrated that the overexpression of wild-type Kv4 α-subunits (which increased Kv4-encoded IA) or expression of a inactive Kv4 mutant protein resulted in increased density of the hyperpolarization activated current, Ih (MacLean et al., 2003). Together, the remodeling of Kv currents evident in response to the disruption of the expression of multiple KChIPs and the finding of decreased expression levels of KChIP proteins in samples from Kv4.2−/− mice suggests that the KChIPs, through direct or indirect effects, may play important roles in balancing the expression of ionic conductances in cortical pyramidal neurons. Clearly, future experiments aimed at exploring this possibility will be of considerable interest.
Footnotes
This work was supported by National Institutes of Health Grant NS030676 (J.M.N.), National Eye Institute Institutional Training Grant T32-EY013360 (A.J.N.), and National Heart Lung and Blood Institute Institutional Training Grant T32-HL007275 (N.C.F.). We thank Amy Huntley for the preparation and maintenance of glia cultures, Rebecca Mellor for assistance with quantitative PCR, and Rick Wilson for the maintenance and screening of the mouse lines used in this study. We also thank Dr. Kai-Chien Yang and Dr. Yarimar Carrasquillo for many valuable discussions and for comments on this manuscript. The KChIP3 knock-out mice were kindly provided by Dr. Mark Bowlby (Wyeth Ayerst Pharmaceuticals, Princeton, NJ), and the KChIP2 knock-out mice were provided by Dr. Masa Hoshijima (University of California, San Diego, La Jolla, CA).
- Correspondence should be addressed to Jeanne M. Nerbonne, Department of Developmental Biology, Washington University School of Medicine, Campus Box 8103, 660 South Euclid Avenue, St. Louis, MO 63110. jnerbonne{at}wustl.edu